Compare IMTX & MBWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMTX | MBWM |
|---|---|---|
| Founded | N/A | 1997 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 992.8M | 1.1B |
| IPO Year | 2020 | 1997 |
| Metric | IMTX | MBWM |
|---|---|---|
| Price | $6.32 | $59.52 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 6 |
| Target Price | $15.97 | ★ $64.17 |
| AVG Volume (30 Days) | ★ 1.0M | 98.0K |
| Earning Date | 11-10-2026 | 10-20-2026 |
| Dividend Yield | N/A | ★ 2.68% |
| EPS Growth | N/A | ★ 10.95 |
| EPS | N/A | ★ 4.21 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $16.34 |
| Revenue Next Year | $14.22 | $7.39 |
| P/E Ratio | ★ N/A | $14.16 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.06 | $43.84 |
| 52 Week High | $12.41 | $63.41 |
| Indicator | IMTX | MBWM |
|---|---|---|
| Relative Strength Index (RSI) | 36.00 | 43.37 |
| Support Level | N/A | $58.49 |
| Resistance Level | $7.95 | $59.71 |
| Average True Range (ATR) | 0.47 | 1.42 |
| MACD | -0.01 | -0.20 |
| Stochastic Oscillator | 19.81 | 5.01 |
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.